Show Stocks and Investing Publications

• Thu, January 23, 2025

by: MSN

Avidity Biosciences CFO sells $93,985 in stock

Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company stock valued at approximately $93,985. The transactions occurred on January 21,

by: Forbes

S&P 500 Index Funds: Risks You Must Know Before You Invest

Low cost S&P 500 index funds are fantastic investment vehicles but they are not without risks. We discuss these risks and how to best think about them.

by: MSN

2 'Strong Buy'-Rated Dividend Stocks With Yields Above 7% for 2025

Investing in dividend stocks with a high yield of more than 7% can significantly boost your portfolio's income potential, especially in a low-interest-rate environment. However, targeting companies with sustainable dividend payouts is crucial,

by: MSN

Altimmune's SWOT analysis: pemvidutide potential drives stock outlook

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention from analysts and investors alike.

by: MSN

Diamondback Energy's SWOT analysis: stock poised for growth amid merger synergies

Diamondback Energy Inc (NASDAQ:FANG), a leading independent oil and gas company focused on the Permian Basin with a market capitalization of $51.48 billion, has been making significant strides in operational efficiency and strategic growth.

by: MSN

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

The exposÃ© led to the company's CEO going to jail and to Anderson's short-selling firm, Hindenburg Research, becoming one of the most feared names in corporate America. When Anderson announced last Wednesday that Hindenburg was closing shop,

• Fri, January 24, 2025

by: WOPRAI

Matthew Smith Maintained (HSY) at Hold with Decreased Target to $170 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HAIN) at Hold with Decreased Target to $7 on, Jan 24th, 2025

by: WOPRAI

Gil Luria Maintained (GOOGL) at Neutral with Increased Target to $200 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (GIS) at Buy with Decreased Target to $72 on, Jan 24th, 2025

by: WOPRAI

Matthew Akers Maintained (GE) at Overweight with Increased Target to $250 on, Jan 24th, 2025

by: WOPRAI

Ken Herbert Maintained (GE) at Outperform with Increased Target to $220 on, Jan 24th, 2025

by: WOPRAI

Terry McEvoy Reiterated (FMBH) at Equal and Held Target at $43 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (FLS) at Buy with Increased Target to $75 on, Jan 24th, 2025

by: WOPRAI

Brian Brophy Maintained (FIX) at Buy with Increased Target to $577 on, Jan 24th, 2025

by: WOPRAI

Orest Wowkodaw Maintained (FCX) at Sector with Decreased Target to $45 on, Jan 24th, 2025

by: WOPRAI

Jay Olson Downgraded (EXEL) to Perform and Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Jared Shaw Maintained (EWBC) at Overweight with Decreased Target to $120 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (ESS) at Equal with Decreased Target to $302 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (EQR) at Overweight with Decreased Target to $79 on, Jan 24th, 2025

by: WOPRAI

Jeffrey Bernstein Maintained (EAT) at Equal with Increased Target to $150 on, Jan 24th, 2025

by: WOPRAI

Jeffrey Bernstein Maintained (DPZ) at Underweight with Decreased Target to $402 on, Jan 24th, 2025

by: WOPRAI

Richard Shane Maintained (DFS) at Neutral with Increased Target to $169 on, Jan 24th, 2025

by: WOPRAI

Karl Shepard Maintained (DFS) at Sector with Increased Target to $210 on, Jan 24th, 2025

by: WOPRAI

Wood Lay Maintained (CWBC) at Market with Decreased Target to $22 on, Jan 24th, 2025

by: WOPRAI

Matt Breese Reiterated (CUBI) at Equal and Held Target at $58 on, Jan 24th, 2025

by: WOPRAI

Patrick Brown Reiterated (CSX) at Outperform with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

James McGarragle Maintained (CSX) at Sector with Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Brian Ossenbeck Maintained (CSX) at Overweight with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

Brandon Oglenski Maintained (CSX) at Overweight with Decreased Target to $38 on, Jan 24th, 2025

by: WOPRAI

Benjamin Hartford Maintained (CSX) at Outperform with Decreased Target to $38 on, Jan 24th, 2025

by: WOPRAI

Ariel Rosa Maintained (CSX) at Buy with Decreased Target to $39 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (CR) at Hold with Decreased Target to $170 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (CPT) at Overweight with Decreased Target to $126 on, Jan 24th, 2025

by: WOPRAI

Lisa Gill Maintained (COR) at Overweight with Increased Target to $301 on, Jan 24th, 2025

by: WOPRAI

Christopher Mcgratty Maintained (COLB) at Market with Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Patrick Scholes Maintained (CCL) at Hold with Increased Target to $30 on, Jan 24th, 2025

by: WOPRAI

Lisa Gill Maintained (CAH) at Neutral with Increased Target to $142 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (CAG) at Hold with Decreased Target to $28 on, Jan 24th, 2025

by: WOPRAI

Matthew Akers Maintained (CACI) at Overweight with Increased Target to $536 on, Jan 24th, 2025

by: WOPRAI

Joseph Greff Maintained (BYD) at Neutral with Increased Target to $80 on, Jan 24th, 2025

by: WOPRAI

Fawne Jiang Reiterated (BIDU) at Buy and Held Target at $130 on, Jan 24th, 2025

by: WOPRAI

David Williams Reiterated (BDC) at Buy and Held Target at $130 on, Jan 24th, 2025

by: WOPRAI

Jared Shaw Maintained (BANC) at Overweight with Decreased Target to $19 on, Jan 24th, 2025

by: WOPRAI

Jason Gursky Maintained (BA) at Buy with Decreased Target to $207 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (AVB) at Equal with Decreased Target to $230 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Downgraded (AVB) to Equal and Decreased Target to $223 on, Jan 24th, 2025

by: WOPRAI

Karl Shepard Maintained (ASB) at Sector with Increased Target to $27 on, Jan 24th, 2025

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

The exposÃ© led to the company's CEO going to jail and to Anderson's short-selling firm, Hindenburg Research, becoming one of the most feared names in corporate America. When Anderson announced last Wednesday that Hindenburg was closing shop,

The article discusses the diminishing presence of high-profile short sellers in the financial markets, highlighted by the exit of notable figures like Hindenburg Research and Andrew Left. Short selling, a strategy where investors bet on the decline of a stock's price, has become increasingly risky and less profitable due to several factors. Firstly, the rise of retail investors, often rallying around stocks targeted by short sellers, has led to phenomena like the GameStop short squeeze, making short positions more volatile and dangerous. Secondly, regulatory scrutiny has intensified, with short sellers facing potential legal challenges and investigations, as seen with Hindenburg's report on Adani Group. Additionally, the article notes that the overall market environment, characterized by a long bull run, has made it difficult for short sellers to find viable targets. The combination of these elements has led to a shrinking pool of professional short sellers, with many either retiring or shifting strategies, indicating a significant change in the landscape of Wall Street's traditional roles.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/technology/are-famous-short-sellers-going-extinct-the-exit-of-hindenburg-research-and-andrew-left-shows-the-risky-trade-is-shrinking/ar-AA1xIN9e

Like: 👍

Similar Stocks and Investing Publications

on: Wed, Dec 18th 2024
by: MSN

IPOs Sprint In A Falling Market: Watch Expert's Take Before Investing In Vishal/Mobikwik/Sai Life

What Should Investors Do Next? The stock market may be witnessing a downturn, but three IPOs defied the odds today, delivering exceptional returns to investors. Vishal Mega Mart, Mobikwik, and Sai Life Sciences made stellar market debuts,

on: Fri, Dec 13th 2024
by: bnnbloomberg

Day-Trader Spirits Prove Hard to Kill at Market's Riskiest Edges

A five-day runup in Treasury yields finally tamped down the post-election fervor in big US stocks this week. Not so at the market's speculative edges, where Bitcoin and its memed-up cousins keep testing the limits of speculative zeal.

on: Wed, Dec 11th 2024
by: The Motley Fool Canada

Short-Selling on the TSX: The Stocks Investors Are Betting Against

High-risk investors engage in short-selling, betting against some TSX stocks for bigger profits. The widely used strategy to make money from stocks is to buy low and sell high. You buy at the lowest price point possible, then unload at a much higher price to maximize profits. However, some investors profit from falling share prices.

on: Mon, Dec 09th 2024
by: 24/7 Wall St

Stock Market Today: Nasdaq Composite and S&P 500 Fall While Applovin (APP) Plummets

Live Updates Make sure to refresh this page periodically for updates. Sectors Outperforming Today 10:31 am The S&P 500 remains slightly red on the day, but some sectors are seeing better performance.

on: Fri, Nov 29th 2024
by: Thomas Matters

Wall Street weekly outlook: Jobs data set to pave way for rates path, stocks

Stocks are heading into December with the benchmark S&P 500 near record highs following an over 25% year-to-date gain.

on: Fri, Nov 29th 2024
by: Thomas Matters

10 Tech and Communication Stocks With High Short Interest That Are On Retail's Radar

The stock market has been on a tear for a second year in running, with the S&P 500 Index, a measure of broader market performance, up over 25% so far this year. More upside is likely as the market enters into the seasonally strong month of December.

on: Tue, Jan 21st 2025
by: MSN

Monday's Insider Activity: Quiet Day with No Significant Trades

No significant insider purchases were reported for Monday, January 20, 2025. Top Sells: No significant insider sales were reported for Monday, January 20, 2025. Investors should s

on: Fri, Jan 17th 2025
by: Kiplinger

Stock Market Today: Stocks Jump Ahead of Trump Inauguration

Stocks closed out the week with a bang as Treasury yields retreated from recent highs. Optimism is swirling ahead of President-elect Donald Trump's inauguration on Monday, which also happens to be a stock market holiday. Indeed, both the equities and bond markets will be closed in observance of Martin Luther King Jr. Day.

on: Thu, Jan 16th 2025
by: Reuters

Wall Street could get a boost from $1 trillion in buybacks, Goldman says

Investors have been hoping Donald Trump's return to the White House next week will boost the U.S. stock market, while Goldman Sachs sees stocks benefiting from the biggest expected company buybacks in at least five years.

on: Wed, Jan 15th 2025
by: dailyinvestor

Five JSE stocks that left investors in tears

The five worst-performing shares on the JSE in 2024 were Sasol, Renergen, Montauk Renewables, Gemfields, and Jubilee Metals. South Africa's stock market performed well in the second half of the year after a favourable election outcome.

on: Wed, Jan 15th 2025
by: MSN

The Notebook: Impulse investing? How FOMO is driving young investors

New research has shown how fast-changing trends are driving investing among young Brits. But will they regret throwing out the fundamentals?

on: Wed, Jan 15th 2025
by: ABC

Stock market today: Wall Street ticks up ahead of latest inflation data, start of earnings season

Wall Street pointed modestly higher ahead of this week's latest U.S. inflation reports and the unofficial start of earnings season